MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
TCON
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

TRACON Pharmaceuticals (TCON) Ownership - Who owns TRACON Pharmaceuticals?

TRACON Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing its cost efficient, contract research organization (CRO) independent product development platform to partner with ex-U... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
357.79K
P/E Ratio
0.02
Total Cash
6.27M
Projected Growth
N/A
Total Debt
236K
Revenue
3.2M
Risk (Beta)
0.96
Dividend Yield
N/A
Total Cash/Share
1.84
Total Debt/Equity
N/A
Revenue/Share
1.41 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for TCON
A.I. Advisor
published General Information

General Information

a provider of therapies for cancer and related diseases

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A